Redhill Biopharma Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Redhill Biopharma Ltd., a foreign private issuer based in Tel Aviv, Israel, on March 13, 2013. The report covers the month of March 2013 and serves to disclose a scheduled corporate presentation rather than financial results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is an informational notice regarding an upcoming event and contains no financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled presentation by the Chief Executive Officer.
Guidance, Outlook, and Management Commentary
Dr. Dror Ben-Asher, the Company's Chief Executive Officer, is scheduled to present an overview of the Company at the 25th Annual ROTH Conference. The event will take place in Laguna Niguel, California, from March 17-20, 2013. The specific presentation is set for Tuesday, March 19, 2013, at 10:30 am PDT. A copy of the presentation materials has been uploaded to the Company's investor relations website.
Key Facts for Investor Verification
- Verify the date and time of the CEO presentation at the ROTH Conference (March 19, 2013, 10:30 am PDT).
- Access the presentation materials via the Company's website at http://ir.redhillbio.com/events.cfm.
- Note that this filing contains no financial data; investors should refer to the Company's Form 20-F for financial statements.